Purity independent subtyping of tumors (PurIST), a clinically robust, single-sample classifier for tumor subtyping in pancreatic cancer

NU Rashid, XL Peng, C Jin, RA Moffitt, KE Volmar… - Clinical Cancer …, 2020 - AACR
Purpose: Molecular subtyping for pancreatic cancer has made substantial progress in recent
years, facilitating the optimization of existing therapeutic approaches to improve clinical …

Consensus on molecular subtypes of high-grade serous ovarian carcinoma

GM Chen, L Kannan, L Geistlinger, V Kofia… - Clinical Cancer …, 2018 - AACR
Purpose: The majority of ovarian carcinomas are of high-grade serous histology, which is
associated with poor prognosis. Surgery and chemotherapy are the mainstay of treatment …

The current staging and classification systems of breast cancer and their pitfalls: Is it possible to integrate the complexity of this neoplasm into a unified staging system …

FAC da Luz, BJ Araujo, RA de Araujo - Critical Reviews in Oncology …, 2022 - Elsevier
Breast cancer is one of the leading causes of cancer death in women worldwide due to its
variable aggressiveness and high propensity to develop distant metastases. The staging …

[HTML][HTML] Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases

N Priedigkeit, RJ Watters, PC Lucas, A Basudan… - JCI insight, 2017 - ncbi.nlm.nih.gov
Bone metastases (BoM) are a significant cause of morbidity in patients with estrogen
receptor–positive (ER-positive) breast cancer; yet, characterizations of human specimens …

Feature selection in clinical proteomics: with great power comes great reproducibility

W Wang, ACH Sue, WWB Goh - Drug Discovery Today, 2017 - Elsevier
Highlights•Null-hypothesis statistical testing is irreproducible because of P-value variability.•
Irreproducibility can be circumvented by boosting power.•Increasing sample size and …

TimiGP: Inferring cell-cell interactions and prognostic associations in the tumor immune microenvironment through gene pairs

C Li, B Zhang, E Schaafsma, A Reuben, L Wang… - Cell Reports …, 2023 - cell.com
Determining the prognostic association of different immune cell types in the tumor
microenvironment is critical for understanding cancer biology and developing new …

Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models

L Li, ZP Liu - Journal of translational medicine, 2021 - Springer
Background The successful identification of breast cancer (BRCA) prognostic biomarkers is
essential for the strategic interference of BRCA patients. Recently, various methods have …

Alternative empirical Bayes models for adjusting for batch effects in genomic studies

Y Zhang, DF Jenkins, S Manimaran, WE Johnson - BMC bioinformatics, 2018 - Springer
Background Combining genomic data sets from multiple studies is advantageous to
increase statistical power in studies where logistical considerations restrict sample size or …

Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma

K Liu, Y Geng, L Wang, H Xu, M Zou, Y Li… - Molecular …, 2022 - Wiley Online Library
Resistance to gemcitabine is the main challenge of chemotherapy for pancreatic ductal
adenocarcinoma (PDAC). Hence, the development of a response signature to gemcitabine …

The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB

Y Okita, M Kimura, R Xie, C Chen, LTW Shen… - Science …, 2017 - science.org
Triple-negative breast cancer (TNBC) is particularly aggressive and difficult to treat. For
example, the transforming growth factor–β (TGF-β) pathway is implicated in TNBC …